<p>蓝鸟公司（NASDAQ:BLBD - 获取免费报告）周二的股价下跌了 8.5%。该公司的股价最低曾达到 68.05 美元，最后交易价格为 66.5450 美元。在午盘交易中，约有 30,194 股成交，较平均每日成交量 434,964 股下降了 93%。该股票此前收盘价为 72.74 美元。</p>
<h2>分析师设定新的价格目标</h2>
<ul>
<li>对于看涨投资者的三大高风险高回报投资</li>
</ul>
<p>多家券商最近对 BLBD 发布了报告。Needham &amp; Company LLC 将蓝鸟的目标价从 78.00 美元上调至 86.00 美元，并在 5 月 7 日的报告中给予该公司 “买入” 评级。巴克莱将蓝鸟的目标价从 55.00 美元上调至 75.00 美元，并在 5 月 7 日的研究报告中给予该股票 “超配” 评级。华尔街 Zen 将蓝鸟的股票评级从 “强烈买入” 下调至 “买入”，该报告于 2 月 7 日发布。Freedom Capital 将蓝鸟的股票评级从 “强烈买入” 下调至 “持有”，该研究报告于 5 月 7 日发布。最后，BTIG Research 将蓝鸟的股票目标价从 65.00 美元上调至 80.00 美元，并在 5 月 7 日的报告中给予该公司 “买入” 评级。六位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，蓝鸟的平均评级为 “适度买入”，共识目标价为 75.80 美元。</p>
<p><strong>查看我们关于 BLBD 的最新股票报告</strong></p>
<h2>蓝鸟股票表现</h2>
<ul>
<li>CRISPR Therapeutics 是基因编辑领域的 NVIDIA 吗？</li>
</ul>
<p>该公司的 50 日移动平均线为 60.89 美元，200 日移动平均线为 55.32 美元。公司的速动比率为 1.27，流动比率为 1.83，债务与股本比率为 0.28。公司的市值为 20.5 亿美元，市盈率为 15.86，市盈增长比率为 1.01，贝塔值为 1.38。</p>
<p>蓝鸟（NASDAQ:BLBD - 获取免费报告）最近在 5 月 6 日发布了季度财报。该公司报告季度每股收益为 1.00 美元，超出市场共识预期的 0.88 美元，超出幅度为 0.12 美元。蓝鸟的股本回报率为 53.68%，净利润率为 8.91%。该公司在本季度的收入为 3.5264 亿美元，而分析师预期为 3.3523 亿美元。在去年同期，该公司每股收益为 0.96 美元。蓝鸟的收入同比下降了 1.7%。整体来看，研究分析师预测蓝鸟公司在当前财政年度将发布 4.35 美元的每股收益。</p>
<h2>蓝鸟的内部交易</h2>
<ul>
<li>基因疗法：为什么单次治疗要花费数百万？</li>
</ul>
<p>在相关消息中，首席运营官 Jeffrey Scott Sanfrey 在 3 月 4 日的交易中出售了 5,192 股股票。股票的平均售价为 58.54 美元，总价值为 303,939.68 美元。出售完成后，首席运营官直接持有公司 39,011 股股票，价值约为 2,283,703.94 美元。这代表其持股比例下降了 11.75%。该交易已在 SEC 的法律文件中披露，您可以通过此链接访问。此外，首席财务官 Razvan Radulescu 在 2 月 19 日的交易中出售了 3,925 股公司的股票。该股票的平均售价为 60.98 美元，总交易额为 239,346.50 美元。出售后，首席财务官持有公司 42,255 股股票，价值约为 2,576,709.90 美元。该交易使其持股比例下降了 8.50%。该交易的披露信息可在 SEC 文件中找到。公司内部人士持有公司股票的 1.10%。</p>
<h2>蓝鸟的机构交易</h2>
<p>机构投资者和对冲基金最近调整了对该公司的持股。洛克菲勒资本管理公司在第四季度将其在蓝鸟的持股增加了 210.0%。洛克菲勒资本管理公司现在拥有 775 股公司股票，价值 36,000 美元，此前在该期间内又购买了 525 股。Transamerica Financial Advisors LLC 在第四季度将其在蓝鸟的持股增加了 222.7%。Transamerica Financial Advisors LLC 现在拥有 823 股公司股票，价值 39,000 美元，此前在该期间内又收购了 568 股。凯通国际资产管理有限公司在第三季度将其在蓝鸟的持股增加了 10,028.6%。凯通国际资产管理有限公司现在拥有 709 股公司股票，价值 41,000 美元，此前在上个季度又收购了 702 股。Aster Capital Management DIFC Ltd 在第四季度购买了蓝鸟的新头寸，价值约为 41,000 美元。最后，Mcguire Capital Advisors Inc.在第四季度购买了蓝鸟的新头寸，价值约为 63,000 美元。目前 93.59% 的股票由机构投资者持有。</p>
<h2>关于蓝鸟</h2>
<p>（获取免费报告）</p>
<p>蓝鸟公司（NASDAQ: BLBD）是一家领先的公交车和公共交通工具制造商，总部位于乔治亚州的福特谷。公司的核心业务包括设计、工程和生产校车和活动巴士，产品线包括常规（C 型）车型、公交风格（D 型）车型以及特殊需求和活动运输的特殊配置。近年来，蓝鸟扩大了其产品范围，包括零排放电动校车，体现了其对先进推进技术和环境可持续性的承诺。</p>
<p>蓝鸟成立于 1927 年，在学生交通运输领域建立了安全和可靠的声誉。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票超过 Blue Bird</li>
<li>家得宝的抛售可能成为一个巨大的机会</li>
<li>五角大楼的人工智能转型为国防股票注入动力</li>
<li>AAPL：忘掉 iPhone——服务将推动下一个增长阶段</li>
<li>Ackman 和 Berkshire 在人工智能上相互对赌</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Blue Bird 吗？</h2>
<p>在你考虑 Blue Bird 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Blue Bird 并不在名单上。</p>
<p>虽然 Blue Bird 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

BLBD

<p>蓝鸟公司（NASDAQ:BLBD）股价下跌 8.5%，至 66.54 美元，交易量较平均水平下降 93%。分析师对该公司的评级不一，目标股价范围在 55 美元到 86 美元之间。公司报告每股收益为 1.00 美元，超出预期，但收入同比下降 1.7%。有内部人士出售股票的情况，并且机构投资者显著增加了持股</p>

<p>Blue Bird Corporation (NASDAQ:BLBD - Get Free Report)'s share price was down 8.5% during trading on Tuesday . The company traded as low as $68.05 and last traded at $66.5450. Approximately 30,194 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 434,964 shares. The stock had previously closed at $72.74.</p>
<div class="lb-trans"><p>蓝鸟公司（NASDAQ:BLBD - 获取免费报告）周二的股价下跌了 8.5%。该公司的股价最低曾达到 68.05 美元，最后交易价格为 66.5450 美元。在午盘交易中，约有 30,194 股成交，较平均每日成交量 434,964 股下降了 93%。该股票此前收盘价为 72.74 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的价格目标</h2>
</div><ul>
<li>Top 3 High-Risk, High-Reward Plays for Bullish Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>对于看涨投资者的三大高风险高回报投资</li>
</ul>
</div><p>A number of brokerages have recently issued reports on BLBD. Needham &amp; Company LLC upped their price target on Blue Bird from $78.00 to $86.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, May 7th. Barclays boosted their target price on Blue Bird from $55.00 to $75.00 and gave the stock an &#34;overweight&#34; rating in a research report on Thursday, May 7th. Wall Street Zen downgraded shares of Blue Bird from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday, February 7th. Freedom Capital lowered shares of Blue Bird from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, May 7th. Finally, BTIG Research boosted their price objective on shares of Blue Bird from $65.00 to $80.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Blue Bird has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $75.80.</p>
<div class="lb-trans"><p>多家券商最近对 BLBD 发布了报告。Needham &amp; Company LLC 将蓝鸟的目标价从 78.00 美元上调至 86.00 美元，并在 5 月 7 日的报告中给予该公司 “买入” 评级。巴克莱将蓝鸟的目标价从 55.00 美元上调至 75.00 美元，并在 5 月 7 日的研究报告中给予该股票 “超配” 评级。华尔街 Zen 将蓝鸟的股票评级从 “强烈买入” 下调至 “买入”，该报告于 2 月 7 日发布。Freedom Capital 将蓝鸟的股票评级从 “强烈买入” 下调至 “持有”，该研究报告于 5 月 7 日发布。最后，BTIG Research 将蓝鸟的股票目标价从 65.00 美元上调至 80.00 美元，并在 5 月 7 日的报告中给予该公司 “买入” 评级。六位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，蓝鸟的平均评级为 “适度买入”，共识目标价为 75.80 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on BLBD</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 BLBD 的最新股票报告</strong></p>
</div><h2>Blue Bird Stock Performance</h2>
<div class="lb-trans"><h2>蓝鸟股票表现</h2>
</div><ul>
<li>Is CRISPR Therapeutics the NVIDIA of gene editing?</li>
</ul>
<div class="lb-trans"><ul>
<li>CRISPR Therapeutics 是基因编辑领域的 NVIDIA 吗？</li>
</ul>
</div><p>The business's fifty day moving average is $60.89 and its 200-day moving average is $55.32. The company has a quick ratio of 1.27, a current ratio of 1.83 and a debt-to-equity ratio of 0.28. The company has a market cap of $2.05 billion, a PE ratio of 15.86, a P/E/G ratio of 1.01 and a beta of 1.38.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均线为 60.89 美元，200 日移动平均线为 55.32 美元。公司的速动比率为 1.27，流动比率为 1.83，债务与股本比率为 0.28。公司的市值为 20.5 亿美元，市盈率为 15.86，市盈增长比率为 1.01，贝塔值为 1.38。</p>
</div><p>Blue Bird (NASDAQ:BLBD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.88 by $0.12. Blue Bird had a return on equity of 53.68% and a net margin of 8.91%.The firm had revenue of $352.64 million during the quarter, compared to analyst estimates of $335.23 million. During the same period in the prior year, the business posted $0.96 EPS. Blue Bird's revenue was down 1.7% on a year-over-year basis. As a group, research analysts predict that Blue Bird Corporation will post 4.35 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>蓝鸟（NASDAQ:BLBD - 获取免费报告）最近在 5 月 6 日发布了季度财报。该公司报告季度每股收益为 1.00 美元，超出市场共识预期的 0.88 美元，超出幅度为 0.12 美元。蓝鸟的股本回报率为 53.68%，净利润率为 8.91%。该公司在本季度的收入为 3.5264 亿美元，而分析师预期为 3.3523 亿美元。在去年同期，该公司每股收益为 0.96 美元。蓝鸟的收入同比下降了 1.7%。整体来看，研究分析师预测蓝鸟公司在当前财政年度将发布 4.35 美元的每股收益。</p>
</div><h2>Insider Transactions at Blue Bird</h2>
<div class="lb-trans"><h2>蓝鸟的内部交易</h2>
</div><ul>
<li>Gene therapy: Why does it cost millions for a single treatment?</li>
</ul>
<div class="lb-trans"><ul>
<li>基因疗法：为什么单次治疗要花费数百万？</li>
</ul>
</div><p>In related news, COO Jeffrey Scott Sanfrey sold 5,192 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $58.54, for a total value of $303,939.68. Following the completion of the sale, the chief operating officer directly owned 39,011 shares of the company's stock, valued at approximately $2,283,703.94. This represents a 11.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Razvan Radulescu sold 3,925 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $60.98, for a total transaction of $239,346.50. Following the sale, the chief financial officer owned 42,255 shares in the company, valued at approximately $2,576,709.90. The trade was a 8.50% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.10% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席运营官 Jeffrey Scott Sanfrey 在 3 月 4 日的交易中出售了 5,192 股股票。股票的平均售价为 58.54 美元，总价值为 303,939.68 美元。出售完成后，首席运营官直接持有公司 39,011 股股票，价值约为 2,283,703.94 美元。这代表其持股比例下降了 11.75%。该交易已在 SEC 的法律文件中披露，您可以通过此链接访问。此外，首席财务官 Razvan Radulescu 在 2 月 19 日的交易中出售了 3,925 股公司的股票。该股票的平均售价为 60.98 美元，总交易额为 239,346.50 美元。出售后，首席财务官持有公司 42,255 股股票，价值约为 2,576,709.90 美元。该交易使其持股比例下降了 8.50%。该交易的披露信息可在 SEC 文件中找到。公司内部人士持有公司股票的 1.10%。</p>
</div><h2>Institutional Trading of Blue Bird</h2>
<div class="lb-trans"><h2>蓝鸟的机构交易</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the company. Rockefeller Capital Management L.P. boosted its holdings in Blue Bird by 210.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 775 shares of the company's stock worth $36,000 after buying an additional 525 shares during the period. Transamerica Financial Advisors LLC raised its holdings in Blue Bird by 222.7% during the fourth quarter. Transamerica Financial Advisors LLC now owns 823 shares of the company's stock valued at $39,000 after acquiring an additional 568 shares during the period. Caitong International Asset Management Co. Ltd lifted its position in shares of Blue Bird by 10,028.6% in the third quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock valued at $41,000 after acquiring an additional 702 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of Blue Bird in the fourth quarter valued at about $41,000. Finally, Mcguire Capital Advisors Inc. bought a new position in shares of Blue Bird in the fourth quarter worth about $63,000. 93.59% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近调整了对该公司的持股。洛克菲勒资本管理公司在第四季度将其在蓝鸟的持股增加了 210.0%。洛克菲勒资本管理公司现在拥有 775 股公司股票，价值 36,000 美元，此前在该期间内又购买了 525 股。Transamerica Financial Advisors LLC 在第四季度将其在蓝鸟的持股增加了 222.7%。Transamerica Financial Advisors LLC 现在拥有 823 股公司股票，价值 39,000 美元，此前在该期间内又收购了 568 股。凯通国际资产管理有限公司在第三季度将其在蓝鸟的持股增加了 10,028.6%。凯通国际资产管理有限公司现在拥有 709 股公司股票，价值 41,000 美元，此前在上个季度又收购了 702 股。Aster Capital Management DIFC Ltd 在第四季度购买了蓝鸟的新头寸，价值约为 41,000 美元。最后，Mcguire Capital Advisors Inc.在第四季度购买了蓝鸟的新头寸，价值约为 63,000 美元。目前 93.59% 的股票由机构投资者持有。</p>
</div><h2>About Blue Bird</h2>
<div class="lb-trans"><h2>关于蓝鸟</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Blue Bird Corporation NASDAQ: BLBD is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company's core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.</p>
<div class="lb-trans"><p>蓝鸟公司（NASDAQ: BLBD）是一家领先的公交车和公共交通工具制造商，总部位于乔治亚州的福特谷。公司的核心业务包括设计、工程和生产校车和活动巴士，产品线包括常规（C 型）车型、公交风格（D 型）车型以及特殊需求和活动运输的特殊配置。近年来，蓝鸟扩大了其产品范围，包括零排放电动校车，体现了其对先进推进技术和环境可持续性的承诺。</p>
</div><p>Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.</p>
<div class="lb-trans"><p>蓝鸟成立于 1927 年，在学生交通运输领域建立了安全和可靠的声誉。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Blue Bird</li>
<li>Why Home Depot’s Sell-Off Could Become a Huge Opportunity</li>
<li>The Pentagon's AI Pivot Supercharges Defense Stocks</li>
<li>AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth</li>
<li>Ackman and Berkshire Are Betting Against Each Other on AI</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Blue Bird</li>
<li>家得宝的抛售可能成为一个巨大的机会</li>
<li>五角大楼的人工智能转型为国防股票注入动力</li>
<li>AAPL：忘掉 iPhone——服务将推动下一个增长阶段</li>
<li>Ackman 和 Berkshire 在人工智能上相互对赌</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Blue Bird Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Blue Bird 吗？</h2>
</div><p>Before you consider Blue Bird, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Blue Bird 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Bird wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Blue Bird 并不在名单上。</p>
</div><p>While Blue Bird currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Blue Bird 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Blue Bird (NASDAQ:BLBD) 股价下跌 8.5% - 是否应该卖出？